(Q43988038)

28 November 2017

title

Phase II trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer (English)

1 reference

28 November 2017

main subject

phase II clinical trial

0 references

1 reference

Keith M Skubitz

1

1 reference

28 November 2017

publication date

1 February 2002

1 reference

Investigational New Drugs

28 November 2017

published in

1 reference

28 November 2017

volume

20

1 reference

28 November 2017

issue

1

1 reference

28 November 2017

page(s)

101-104

1 reference

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

28 November 2017

cites work

1 reference

12 December 2020

Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma

1 reference

12 December 2020

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer

1 reference

12 December 2020

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes

1 reference

12 December 2020

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

12 December 2020

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

1 reference

12 December 2020

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

1 reference

12 December 2020

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1014428720551

1 reference

Dimensions Publication ID

28 November 2017

1009434375

0 references

1 reference